News World Russia rolls out first approved COVID-19 drug as infections pass 500,000

Russia rolls out first approved COVID-19 drug as infections pass 500,000

Russia on Thursday rolled out a drug approved to treat patients suffering from the novel coronavirus, its state financial backer said, as the number of infections there surpassed half a million.

The first deliveries of the new antiviral drug, registered under the name Avifavir, were made to some hospitals and clinics across the country, Russia’s RDIF sovereign wealth fund said in a press release. RDIF has funded trials and has a 50% share in the drug’s manufacturer ChemRar.

The health ministry gave its approval for the drug’s use under a special accelerated process while clinical trials, held over a shorter period and with fewer people than many other countries, were still underway.

There is currently no vaccine for COVID-19, the disease caused by the new coronavirus, and human trials of several existing antiviral drugs have yet to show efficacy.

RDIF chief Kirill Dmitriev last week told Reuters the plan was for ChemRar to manufacture enough of the drug to treat around 60,000 people a month.

Dmitriev on Thursday said more than 10 countries had made requests for Avifavir supplies.

Negotiations were underway to supply the drug to almost all of Russia’s regions, with seven of its more than 80 regions receiving Thursday’s initial deliveries, Dmitriev added.

With 502,436 cases, Russia has the third highest number of infections in the world after Brazil and the United States, but has a relatively low official death toll of 6,532 – something that has been the focus of debate.

The Moscow health department on Wednesday raised its death toll for the month of May, citing changes in the way it determines the cause of death for patients suffering from other health problems.

(Reuters)

FILE PHOTO: A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia May 20, 2020. REUTERS/Anton Vaganov

Top Stories

128 new cases, three deaths announced on Wednesday

The Health Ministry announced the death of three persons due to COVID-19. This raises the death toll from the virus in Cyprus to 193,...

Where to get antigen rapid tests during period 28-31 January

The Health Ministry announced the following antigen rapid test sites during the period 28-31 January 2021: LIMASSOL Church of Agios Ioannis Eleimon, Limassol 08:30-18:30 Cultural Center Mesa...

Israel, Denmark to vaccinate all athletes for Tokyo Olympic Games

Several countries, including Israel and Denmark, said on Wednesday they would vaccinate their athletes and staff against COVID-19 ahead of the Tokyo Olympics, amid...

UK AstraZeneca vaccine plant partially evacuated over suspect package

A factory in Wales that produces AstraZeneca's COVID-19 vaccine was partially evacuated on Wednesday after it received a suspicious package and police said a...

43-year-old arrested for speeding

Members of the Police arrested this morning a 43-year-old man who was seen speeding at the Nicosia-Larnaca road near Koshi village. The man was stopped...

Taste

Squash soup

Ingredients: 1 kg pumpkin, cut into small cubes, approximately 5 cups 2 medium (400g) sweet potatoes, cut into cubes, approximately 2 ½ cups 1 chopped leek, only...

Mezedes

No visit to Cyprus is complete without enjoying the traditional meal of many small dishes known as ‘meze’. This large feast, which has been a...

Prawns with fried cheese, barley shaped pasta

Put the barley shaped pasta into a small pan with salted water, bring to a boil and when tender, drain. Peal the prawns leaving...

Salmon and shrimp sheftalies

Mix all ingredients for tabbouli in a bowl and keep to one side so flavours can combine. Prepare the sheftalies: wash and soak the casing...